Lamfrom, who died in 1984, was Tim Boyle's aunt and the sister of Gert Boyle, Chairman of Columbia Sportswear. She mentored Brian Druker, MD, Director of the OHSU Knight Cancer Institute, whose research led to the development of imatinib.
“I can't think of a more fitting tribute to Hildegard Lamfrom than a mentorship program that will cultivate a new generation of scientific minds pushing the boundaries of their field,” OHSU President Joe Robertson, MD, MBA, said in a news release.
The Boyles' gift is the largest private donation received to date in support of the Knight Cancer Challenge, a $1 billion OHSU fundraising campaign to revolutionize early detection and treatment of cancer. More than $310 million has been raised to date.
Moffitt Cancer Center will name its Precision Molecular Diagnostics Laboratory and new Patient and Family Center after philanthropists Carol and Frank Morsani, who have been longtime supporters of Tampa's health care community and of Moffitt.
“Needless to say, we are very appreciative of this recognition. Our philosophy of philanthropy is an effort to motive and encourage others to participate in the betterment of our community,” Carol Morsani said in a news release. “Few have not been touched by this menacing disease.”
The Morsani Molecular Diagnostics Laboratory is led by Executive Director Anthony M. Magliocco, MD. His research currently focuses on developing clinical biomarkers that can help identify the right drug for a particular patient or determine if a clinical trial is a good match for a patient with a certain tumor gene mutation.
The Morsani Patient and Family Center, scheduled to open next fall, will be part of Moffitt's new McKinley Outpatient Facility, which includes several clinics, an ambulatory surgery center, infusion and imaging facilities, and research labs.
St. Jude Children's Research Hospital's designation as a Comprehensive Cancer Center has been renewed by the National Cancer Institute. St. Jude is the first and only NCI-designated Comprehensive Cancer Center devoted to children. St. Jude has been designated as an NCI cancer center since 1977, and the hospital was named a comprehensive cancer center in 2008.
In other St. Jude news, the following three physician-scientists have been appointed to leadership positions:
- Mitchell Weiss, MD, PhD, has been named Chair of the Department of Hematology. He joins after working most recently at the University of Pennsylvania Perelman School of Medicine and the Children's Hospital of Philadelphia.
- J. Paul Taylor, MD, PhD, who joined the Department of Developmental Neurobiology in 2008, has been appointed Chair of the new Department of Cell and Molecular Biology. He will also hold the Edward F. Barry Endowed Chair in Cell and Molecular Biology.
- Kim Nichols, MD, has been selected to launch the new Division of Hereditary Cancer Predisposition. She is currently Associate Professor of Pediatrics at the UPenn Perelman School of Medicine, where she also directs the CHOP Pediatric Hereditary Cancer Predisposition Program.
- Patricia M. LoRusso, DO, will join Yale Cancer Center as a Professor of Medicine and Associate Director of Innovative Medicine in August. Prior to this appointment she has served in numerous leadership roles at Wayne State University's Barbara Karmanos Cancer Institute, most recently as Director of the Phase I Clinical Trials Program and of the Eisenberg Center for Experimental Therapeutics.
“Pat LoRusso is a pre-eminent leader in early phase drug development, and she joins the cancer center at a time during which we have committed to accelerating the process of getting new drugs to patients,” Thomas J. Lynch, MD, Director of Yale Cancer Center and Physician-in-Chief at Smilow Cancer Hospital at Yale New Haven, said in a news release.
The Association of Community Cancer Centers named the following six cancer programs as recipients of the organization's 2014 Innovator Awards for pioneering solutions in the effective delivery of cancer care:
- DeCesaris Cancer Institute at Anne Arundel Medical Center in Annapolis, Maryland, for a three-year pilot project that focused on three prospective oncology nursing interventions examining quality measures for fatigue, distress, and sleep-wake disturbance, which has led to the development of an advanced NP-led Symptom Management Clinic that provided rapid access and coordination of care with the oncologists and infusions team;
- Beaumont Cancer Institute of Beaumont Health System in Royal Oak, Michigan, for developing and launching an outpatient Nutrition Clinic to improve patients' overall quality of life by decreasing ER visits, re-admissions, and treatment breaks;
- Duke Comprehensive Cancer Center of Duke Oncology Network in Durham, North Carolina, for the Carolinas Palliative Care Database, a community and academic partnership based at Duke University, which uses a web-based tool to collect quality data from physicians at point-of-care to track quality and outcomes in palliative care by offering immediate feedback and highlighting areas of concern;
- New Mexico Oncology Hematology Consultants, Ltd., in Albuquerque, New Mexico, for establishing the “COME HOME” medical home model, which is now being piloted in seven independent community oncology practices and is expected to save more than $33 million in costs in three years;
- Oncology Specialists, SC, in Park Ridge, Illinois, for developing a process for leveraging electronic medical records to create comprehensive survivorship care plans for patients, providing an expansive summary of treatment received, include side effects, health maintenance issues, impact of the cancer diagnosis on the well-being of family members, and other vital information; and
- University Medical Center of Princeton at Plainsboro in New Jersey, for its best-practice process for implementing a system-wide distress screening program that provides patients with comprehensive support services across the continuum of care.
Eddie Reed, Noted Cancer Health Disparities Investigator, Dies at 60
Eddie Reed, MD, Clinical Director of the National Institute on Minority Health and Health Disparities of the National Institutes of Health, died in May at age 60. Reed researched cancer care for the underserved as well as cancer drug development, focusing on DNA damage and repair in cells.
Before he was recruited to the NIMHD in 2012, Reed served as Professor of Oncologic Sciences and the Abraham Mitchell Distinguished Investigator at the University of South Alabama Mitchell Cancer Institute in Mobile. He had also previously served as Chief of the NCI's Pharmacology Branch and the Ovarian Cancer and Metastatic Prostate Cancer Clinic in the Division of Clinical Science.
He was the first African-American branch Chief to serve at the NCI, and had also been Director of the Mary Babb Randolph Cancer Center at West Virginia University in Morgantown and Director of the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention.
Reed was a member of the American Association for Cancer Research for 27 years, having served on several boards and committees, including Chair of the Minorities in Cancer Research (MICR) Council. He was also on the MICR-Jane Cooke Wright Lectureship Award Committee and the Research Grant Review Committee, and was on the editorial boards of Cancer Prevention Research and Molecular Cancer Therapeutics.
“He was a pioneer and leader in cancer research and was a respected mentor and role model for minority investigators. His scientific and clinical contributions have been critical to cancer health disparities and his legacy will live on in future generations of cancer researchers from all racial and ethnic backgrounds,” Chanita Hughes-Halbert, PhD, MICR Council Chair, noted in memoriam for the AACR website.
Reed had also served on the National Advisory Council on Minority Health and Health Disparities and on the Institute of Medicine's National Cancer Policy Forum. He received the United States Public Health Service Commendation Medal twice.
Reed was preceded in death by his son, Edward. He is survived by his wife, Meenakshi, several siblings, and a large extended family.
Share Your News!
Send information and photos for this column to OT@LWWNY.com© 2014 by Lippincott Williams & Wilkins, Inc.
More on ONCOLOGY-TIMES.com...